Website Not Compatible with Internet Explorer

Enabling Precision Medicine for Cardiovascular Disease

FDA-cleared and CE-marked cardiovascular diagnostic image analysis software

images.png
  • 0623T Automated quantification and characterization of coronary atherosclerotic plaque to assess severity of coronary disease, using data from coronary computed tomographic angiography; data preparation and transmission, computerized analysis of data, with review of computerized analysis output to reconcile discordant data, interpretation and rep

  • 0624T data preparation and transmission

  • 0625T computerized analysis of data from coronary computed tomographic angiography

  • 0626T review of computerized analysis output to reconcile discordant data, interpretation and report

The only, non-invasive clinical tool for quantitation of Lipid Rich Necrotic Core & uniquely validated against histopathology

Developed & validated against live tissue specimens 

Informing Stoke Risk & Treatment Determination
Baseline
BEFORE CORONARY.png
One Year Follow Up After Biologic Therapy
aFTER CORONARY.png
LRNC key.png
Measuring Therapeutic Response
 
“Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core,” Choi et. al. 2020, Circulation
 

The ElucidVivo Advantage

Accuracy
(1)
standard care
ElucidVivo®

1

(1)

  • Over 40% improvement in stroke prediction accuracy over stenosis-based guidelines

  • Over 30% improvement in MACE prediction accuracy over current standard of care

(2)

1. As presented at Society for Vascular Surgery conference 2020, "CRISP" trial interim results

2. “Automated plaque analysis for the prognostication of major adverse cardiac events” European Journal of Radiology

Cost-Effectiveness
(1)
standard care
ElucidVivo®
  • Reimbursement for both workflows

  • Reduction in unnecessary, invasive diagnostics that do not need to intervention 

(1) Potential after 1 year when compared to standard care for total health care system due to better outcomes, reduction in overtreatment, and increased provider efficiency

Experience
standard care
ElucidVivo®

  • On-premise software analyzes in minutes

  • Better informed decision-making to improve patient outcomes

  • Non-invasive procedure reduces patient burden & time spent in facility

plaque morphology software

atherosclerotic plaque software

high-risk plaque software

plaque quantification software

atherosclerotic plaque quantification software

image001 (1).png

Clinical Edition

FDA-cleared & CE-marked arterial analysis software for clinical use

image001 (1).png

Research Edition

Arterial analysis software with innovative additional features for research and studies

image001 (1).png

Enterprise

Radiological image and annotation database/knowledgebase system

high-risk plaque software

 
Request a Demo

To schedule a ElucidVivo Demo with one of our product consultants or download a free trial version, please fill in your contact details below

Thanks for submitting!

2 Park Plaza Suite 305
Boston, MA 02116